Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet

Journal of Endocrinology

Volumn 217, Issue 1, 2013, Pages 11-20

  Baldassano, Sara ^a   Amato, Antonella ^a   Cappello, Francesco ^b   Rappa, Francesca ^b   Mulè, Flavia ^a  

^a Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari (STEMBIO)   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

GLP2 receptor expression; Intestinal adaptation; Intestinal morphometry; Obesity

Indexed keywords

CASPASE 3; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR ANTAGONIST; HORMONE ANTAGONIST; KI 67 ANTIGEN; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; GLP 2 RECEPTOR; GLP-2 RECEPTOR; GLUCAGON LIKE PEPTIDE 2 (3 33); GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-2 (3-33); MKI67 PROTEIN, MOUSE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; DUODENUM; JEJUNUM; LIPID DIET; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADAPTATION; ANIMAL; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; INTESTINE MUCOSA; METABOLISM; MOLECULARLY TARGETED THERAPY; OBESITY; PATHOLOGY; SIGNAL TRANSDUCTION; SMALL INTESTINE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTI-OBESITY AGENTS; CELL PROLIFERATION; DIET, HIGH-FAT; DUODENUM; GLUCAGON-LIKE PEPTIDE 2; INTESTINAL MUCOSA; INTESTINE, SMALL; JEJUNUM; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; OBESITY; PEPTIDE FRAGMENTS; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; UP-REGULATION;

MLCS; MLOWN;

EID: 84877108482     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0500     Document Type: Article

References (56)

1. Aldewachi HS, Wright NA, Appleton DR & Watson AJ 1975 The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. Journal of Anatomy 119 105-121.
2. Altmann GG 1972 Influence of starvation and refeeding on mucosal size and epithelial renewal in the rat small intestine. American Journal of Anatomy 133 391-400. (doi:10.1002/aja.1001330403)
3. Amato A, Baldassano S, Serio R & Mulè F 2009 Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. American Journal of Physiology. Gastrointestinal and Liver Physiology 296 G678-G684. (doi:10.1152/ajpgi.90587.2008)
4. Amato A, Rotondo A, Cinci L, Baldassano S, Vannucchi MG & Mulè F 2010 Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon. American Journal of Physiology. Gastrointestinal and Liver Physiology 299 G1038-G1044. (doi:10.1152/ajpgi.00282.2010)
5. Angelone T, Filice E, Quintieri AM, Imbrogno S, Amodio N, Pasqua T, Pellegrino D, Mulè F & Cerra MC 2012 Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart. Nutrition, Metabolism, and Cardiovascular Diseases 22 486-494. (doi:10.1016/j.numecd.2010.07.014)
6. Bahrami J, Yusta B & Drucker DJ 2010 ErbB activity links the glucagonlike peptide-2 receptor to refeeding-induced adaptation in the murine small bowel. Gastroenterology 138 2447-2456. (doi:10.1053/j.gastro.2010.03.006)
7. Baldassano S, Liu S, Qu MH, Mulè F & Wood JD 2009 Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. American Journal of Physiology. Gastrointestinal and Liver Physiology 297 G800-G805. (doi:10.1152/ajpgi.00170.2009)
8. Bjerknes M & Cheng H 2001 Modulation of specific intestinal epithelial progenitors by enteric neurons. PNAS 98 12497-12502. (doi:10.1073/pnas.211278098)
9. Bremholm L, Hornum M, Henriksen BM, Larsen S & Holst JJ 2009 Glucagon-like peptide-2 increases mesenteric blood flow in humans. Scandinavian Journal of Gastroenterology 44 314-319. (doi:10.1080/00365520802538195)
10. Burrin DG, Stoll B, Jiang R, Chang X, Hartmann B, Holst JJ, Greeley GH Jr & Reeds PJ 2000 Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough? American Journal of Clinical Nutrition 71 1603-1610.
11. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, LambertDM et al. 2009 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 1091-1103. (doi:10.1136/gut.2008.165886)
12. Cheeseman CI & Tsang R 1996 The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal hexose transport. American Journal of Physiology. Gastrointestinal and Liver Physiology 271 G477-G482.
13. Cinci L, Faussone-Pellegrini MS, Rotondo A, Rotondo A, Mulè F & Vannucchi MG 2011 GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterology and Motility 23 e383-e392. (doi:10.1111/j.1365-2982.2011.01750.x)
14. Dahly EM, Gillingham MB,GuoZ, Murali SG, Nelson DW, Holst JJ & Ney DM 2003 Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation tomid-small bowel resection. American Journal of Physiology. Gastrointestinal and Liver Physiology 284 G670-G682. (doi:10.1152/ajpgi.00293.2002)
15. De Barros Alencar AC, Neves RH, De Oliveira AV & Machado-Silva JR 2012 Changes in the small intestine of Schistosoma mansoni-infected mice fed a high-fat diet. Parasitology 6 1-10. (doi:10.1017/S0031182011002307)
16. Drucker DJ, Erlich P, Asa SL & Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. PNAS 93 7911-7916. (doi:10.1073/pnas.93.15.7911)
17. Estall JL & Drucker DJ 2006 Glucagon-like peptide-2. Annual Review of Nutrition 26 391-411. (doi:10.1146/annurev.nutr.26.061505.111223)
18. Grey VL, Garofalo C, Greenberg GR & Morin CL 1984 The adaptation of the small intestine after resection in response to free fatty acids. American Journal of Clinical Nutrition 40 1235-1242.
19. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D et al. 2006 GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130 150-164. (doi:10.1053/j.gastro.2005.11.005)
20. Hartmann B, Thulesen J, Kissow H, Thulesen S, Ørskov C, Ropke C, Poulsen SS & Holst JJ 2000 Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141 4013-4020. (doi:10.1210/en.141.11.4013)
21. Hartmann B, Thulesen J, Hare KJ, Kissow H, Ørskov C, Poulsen SS & Holst JJ 2002 Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regulatory Peptides 105 173-179. (doi:10.1016/S0167-0115(02)00013-7)
22. Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, Brubaker PL, Drucker DJ & Adeli K 2009 Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 137 997-1005. (doi:10.1053/j.gastro.2009.05.051)
23. Iakoubov R, Lauffer LM, Trivedi S, Kim YI & Brubaker PL 2009 Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice. Endocrinology 150 4033-4043. (doi:10.1210/en.2009-0295)
24. Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ et al. 2001 Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120 806-815. (doi:10.1053/gast.2001.22555)
25. Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J & Mortensen PB 2005 Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 1224-1231. (doi:10.1136/gut.2004.061440)
26. Koopmann MC, Nelson DW, Murali SG, Liu X, Brownfield MS, Holst JJ & Ney DM 2008 Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. Journal of Parenteral and Enteral Nutrition 32 254-265. (doi:10.1177/0148607108316198)
27. Lee SJ, Lee J, Li KK, Holland D, Maughan H, Guttman DS, Yusta B & Drucker DJ 2012 Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis. Endocrinology 153 1141-1151. (doi:10.1210/en.2011-1954)
28. Little TJ, Horowitz M & Feinle-Bisset C 2007 Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. American Journal of Clinical Nutrition 86 531-541.
29. McDonagh SC, Lee J, Izzo A & Brubaker PL 2007 Role of glial cell-line derived neurotropic factor family receptor a2 in the actions of the glucagon-like peptides on the murine intestine. American Journal of Physiology. Gastrointestinal and Liver Physiology 293 G461-G468. (doi:10.1152/ajpgi.00424.2006)
30. Meier JJ, Nauck MA, Pott A, Heinze K, Goetze O, Bulut K, Schmidt WE, Gallwitz B & Holst JJ 2006 Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130 44-54. (doi:10.1053/j.gastro.2005.10.004)
31. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H et al. 1999 Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. PNAS 96 1569-1573. (doi:10.1073/pnas.96.4.1569)
32. Nagell CF, Wettergren A, Pedersen JF, Mortensen D & Holst JJ 2004 Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scandinavian Journal of Gastroenterology 39 353-358. (doi:10.1080/00365520410004424)
33. Nelson DW, Murali SG, Liu X, Koopmann MC, Holst JJ & Ney DM 2008 Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 R1175-R1184. (doi:10.1152/ajpregu.00238.2007)
34. Ørskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ & Holst JJ 2005 GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regulatory Peptides 124 105-112. (doi:10.1016/j.regpep.2004.07.009)
35. Petersen YM, Hartmann B, Holst JJ, Le Huerou-Luron I, BjØrnvad CR & Sangild PT 2003 Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development. Journal of Nutrition 133 1781-1786.
36. Rotondo A, Amato A, Baldassano S, Lentini L & Mulè F 2011 Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 32 1587-1592. (doi:10.1016/j.peptides.2011.06.031)
37. Sagher FA, Dodge JA, Johnston CF, Shaw C, Buchanan KD & Carr KE 1991 Rat small intestinal morphology and tissue regulatory peptides effects of high dietary fat. British Journal of Nutrition 65 21-28. (doi:10.1079/BJN19910062)
38. Scoaris CR, Rizo GV, Roldi LP, de Moraes SM, de Proença AR, Peralta RM & Natali MR 2010 Effects of cafeteria diet on the jejunum in sedentary and physically trained rats. Nutrition 26 312-320. (doi:10.1016/j.nut.2009.04.012)
39. Scott RB, Kirk D, MacNaughton WK & Meddings JB 1998 GLP-2 augments the adaptive response to massive intestinal resection in rat. American Journal of Physiology 275 G911-G921.
40. Shin ED, Estall JL, Izzo A, Drucker DJ & Brubaker PL 2005 Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128 1340-1353. (doi:10.1053/j.gastro.2005.02.033)
41. Sinclair EM & Drucker DJ 2005 Proglucagon-derived peptides mechanisms of action and therapeutic potential. Physiology 20 357-365. (doi:10.1152/physiol.00030.2005)
42. Singh A, Balint JA, Edmonds RH & Rodgers JB 1972 Adaptive changes of the rat small intestine in response to a high fat diet. Biochimica et Biophysica Acta 260 708-715. (doi:10.1016/0005-2760(72)90019-7)
43. Stephens J, Stoll B, Cottrell J, Chang X, Helmrath M & Burrin DG 2006 Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 R283-R289. (doi:10.1152/ajpregu.00588.2005)
44. Sukhotnik I, Mor-Vaknin N, Drongowski RA, Miselevich I, Coran AG & Harmon CM 2004 Effect of dietary fat on early morphological intestinal adaptation in a rat with short bowel syndrome. Pediatric Surgery International 20 419-424. (doi:10.1007/s00383-004-1168-9)
45. Taylor-Edwards CC, Burrin DG, Matthews JC, McLeod KR, Holst JJ & Harmon DL 2010 Expression of mRNA for proglucagon and glucagonlike peptide-2 (GLP-2) receptor in the ruminant gastrointestinal tract and the influence of energy intake. Domestic Animal Endocrinology 39 181-193. (doi:10.1016/j.domaniend.2010.05.002)
46. Thomson ABR, Keelan M & Wild GE 1996 Nutrients and intestinal adaptation. Clinical and Investigative Medicine 19 331-345.
47. Thulesen J, Knudsen LB, Hartmann B, Hastrup S, Kissow H, Jeppesen PB, Ørskov C, Holst JJ & Poulsen SS 2002 The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist. Regulatory Peptides 103 9-15. (doi:10.1016/S0167-0115(01)00316-0)
48. Trivedi S, Wiber SC, El-Zimaity HM & Brubaker PL 2012 Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer. American Journal of Physiology. Gastrointestinal and Liver Physiology 302 G840-G849. (doi:10.1152/ajpgi.00505.2011)
49. Williamson RCN & Chir MB 1978 Intestinal adaptation: mechanisms of control. New England Journal of Medicine 298 1444-1450. (doi:10.1056/NEJM197806292982604)
50. de Wit NJ, Bosch-Vermeulen H, de Groot PJ, Hooiveld GJ, Bromhaar MM, Jansen J, MüllerM& van der Meer R 2008 The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Medical Genomics 1 14. (doi:10.1186/1755-8794-1-14)
51. de Wit NJ, Boekschoten MV, Bachmair E-M, Hooiveld GJ, de Groot PJ, Rubio-Aliaga I, Daniel H & Müller M 2011 Dose-dependent effects of dietary fat on development of obesity in relation to intestinal differential gene expression in C57BL/6J mice. PLoS ONE 6 e19145. (doi:10.1371/journal.pone.0019145)
52. Wojdemann M, Wettergren A, Hartmann B & Holst JJ 1998 Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scandinavian Journal of Gastroenterology 33 828-832.
53. Wojdemann M, Wettergren A, Hartmann B, Hilsted L & Holst JJ 1999 Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. Journal of Clinical Endocrinology and Metabolism 84 2513-2517. (doi:10.1210/jc.84.7.2513)
54. Xiao Q, Boushey RP, Drucker DJ & Brubaker PL 1999 Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117 99-105. (doi:10.1016/S0016-5085(99)70555-X)
55. Yusta B, Huang L, Munroe D, Fantaske R, Sharma S, Demchyshyn L, Asa SL & Drucker DJ 2000 Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119 744-755. (doi:10.1053/gast.2000.16489)
56. Zhou J, Hegsted M, McCutcheon KL, Keenan MJ, Xi X, Raggio AM & Martin RJ 2006 Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity 14 683-689. (doi:10.1038/oby.2006.77)